In a new article floating around social media, the FDA has released a consumer update on their website addressing the deeming regulations and what they consider satisfactory responses to public outcry.
The article gives considerable focus to the effect on youth, claiming that nicotine is to blame. But in an infuriately ironic turn, they end the article with a list of nicotine-based products that the FDA recommends as smoking cessation products:
“The FDA has approved a variety of products as cessation aids to help reduce your dependence on nicotine. Products include nicotine gum, nicotine skin patches, nicotine lozenges, nicotine oral inhaled products, and nicotine nasal spray as well as non-nicotine medications called varenicline and bupropion.”
It’s ridiculous to think the FDA can launch a full-on assault against e-cigarettes due to their nicotine content, but it is perfectly okay to recommend nicotine-based cessation products, such as nicotine gum, patches, and even inhalers.
It just goes to show again the extreme bias against the vaping industry and the legitimate arguments we as a industry have against the FDA and Center for Tobacco Products.